STOUGHTON, Mass. - Collegium Pharmaceutical , Inc. (NASDAQ:COLL), a diversified biopharmaceutical company with a market capitalization of nearly $1 billion and impressive gross profit margins of 87%, ...
In terms of valuation, BioCryst Pharmaceuticals Inc’s market capitalization stands at $1.68 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company ...
Syndax Pharmaceuticals Inc (SNDX) stock saw a modest uptick, ending the day at $14.41 which represents a slight increase of $0.07 or 0.49% from the prior close of $14.34. The stock opened at $14.27 ...
The S&P 500 index trades at a forward price/earnings ratio of 21.9. The U.S. large-cap benchmark stock index is weighted by market capitalization. The index's current forward P/E valuation is 18% ...
China Universal Asset Management Co. Ltd. acquired a new position in scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) in the 4th quarter, Holdings Channel reports. The firm acquired 10,610 shares of ...